Investors

We are a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer.

Our Mission

To advance proven, effective next generation cell therapies for patients with cancer.

To achieve our mission, we are pioneering novel approaches designed to generate T-cells with potent cancer cell-killing capabilities that drive long-lasting clinical responses.